SPECIAL BULLETIN COVID-19 #25: Emergency Update to NC Medicaid and NC Health Choice Preferred Drug List (PDL) and REMS Program Flexibilities

Author: GDIT, (800) 688-6696

Preferred Drug List (PDL) Update

Effective March 25, 2020, due to drug shortages in the marketplace, the NC Medicaid and NC Health Choice PDL Category of “Respiratory: Beta-Adrenergic Handheld, Short Acting” has changed to the following:

Preferred Non-Preferred
albuterol HFA inhaler (generic for Proair® HFA Inhaler / Proventil® HFA Inhaler / Ventolin® HFA Inhaler) levalbuterol HFA inhaler (generic for Xopenex® HFA Inhaler)
Proair® HFA Inhaler  Proair® DigihalerTM Inhaler
Proair® RespiClick® Inhaler  
Proventil® HFA Inhaler  
Ventolin® HFA Inhaler  
Xopenex® HFA Inhaler  

Please visit the following site for a full PDL listing: https://medicaid.ncdhhs.gov/documents/preferred-drug-list 

Updated Guidance for REMS Requirements

NC Medicaid would like to share information about recent FDA guidance regarding REMS requirements during the COVID-19 public health emergency.
Please visit https://www.fda.gov/media/136317/download for the current recommendations. 
 

This blog is related to:

https://medicaid.ncdhhs.gov/blog/2020/03/27/special-bulletin-covid-19-25-emergency-update-nc-medicaid-and-nc-health-choice